24/7 Market News: Kraig Labs Unlocks Spider Silk at Scale, Solving a Historical Problem for Nature's Toughest Fiber

Core Insights - Kraig Biocraft Laboratories (OTCQB: KBLB) has achieved a significant milestone by successfully mass-producing spider silk using genetically engineered silkworms, addressing a long-standing challenge in biotechnology [1][2][3] Company Overview - Kraig Biocraft Laboratories is a biotechnology company focused on developing and commercializing spider silk-based fiber technologies, utilizing a proprietary silkworm-based genetic engineering platform [5] - The company aims to produce high-performance, cost-effective, and scalable spider silk materials for various applications, including defense, performance apparel, technical textiles, and medical uses [5] Technological Breakthrough - The company's genetically engineered silkworms serve as a factory for spider silk production, enabling a scalable and sustainable supply chain that was previously unattainable due to the challenges of farming spiders [2][3] - This breakthrough allows spider silk to transition from laboratory research to practical applications, making it accessible to a wide range of industries, including construction, biomedical engineering, and outdoor apparel [3][7] Market Applications - Potential applications for spider silk include stronger and lighter materials for wearables, biodegradable sutures and scaffolds in biomedical engineering, next-generation body armor for defense contractors, and sustainable textiles for outdoor brands [7]